Law channel feed

Phar­ma com­pa­nies ques­tion new EU in­cen­tives as re­vamp ad­vances

Last year
Pharma

Ap­peals court re­vers­es No­var­tis win over Re­gen­eron in Eylea-Lu­cen­tis bat­tle

Last year
Pharma

Fed­er­al ap­peals court rules in fa­vor of Arkansas in PhRMA's suit over 340B ex­pan­sion

Last year
Pharma

Oth­er IRA cas­es could be in­flu­enced by New Jer­sey judge's de­ci­sions, ex­pert says

Last year
Pharma

BeiGene files patent suits against San­doz, MSN Group

Last year
Pharma

Up­dat­ed: Phar­ma com­pa­nies present IRA cas­es in New Jer­sey court

Last year
Pharma

Law­mak­ers call for 'line in the sand' be­tween US and Chi­nese biotech com­pa­nies

Last year
China
Pharma

Drug­mak­ers gear up for joint IRA ar­gu­ments as PhRMA ap­peals Texas ver­dict

Last year
Pharma

Sen. War­ren at­tacks GSK's de­ci­sion to shift in­haler from brand to au­tho­rized gener­ic

Last year
Pharma

Re­pub­li­can sen­a­tors join at­tack on Biden's pro­pos­al to seize drug patents based on price

Last year
Pharma

Drug­mak­ers sub­mit coun­terof­fers as part of first round of drug price ne­go­ti­a­tions

Last year

En­do inks $465M bank­rupt­cy deal set­tling crim­i­nal and civ­il opi­oid cas­es

Last year
Pharma

Judge rules against As­traZeneca in suit over IRA price ne­go­ti­a­tions

Last year
Pharma

Join­ing con­gres­sion­al skep­ti­cism of Chi­na's role in biotech, Biden ex­ec­u­tive or­der tar­gets da­ta pri­va­cy is­sues

Last year
China

San­doz pays out $265M to set­tle part of an­titrust law­suit

Last year
Pharma

Bi­par­ti­san group of law­mak­ers op­pos­es Biden's plan to use 'march-in' to low­er drug prices

Last year
Pharma

Gilead set­tles with Mary­land dis­trib­u­tor over al­leged coun­ter­feit HIV drugs

Last year
Pharma

Unit­ed Ther­a­peu­tics sues FDA over han­dling of Liq­uidia’s new drug ap­pli­ca­tion for tre­pros­tinil

Last year
Pharma
FDA+

Is a mail­box an of­fice? Not ac­cord­ing to the US' bank­rupt­cy ar­gu­ment against Sor­ren­to Ther­a­peu­tics

Last year
Pharma

SCO­TUS jus­tices hint at un­cer­tain fu­ture of Chevron doc­trine in tan­gen­tial case

Last year
FDA+

Up­dat­ed: NJ court says drug­mak­ers can co­or­di­nate their le­gal fight against the gov­ern­men­t's price ne­go­ti­a­tions

Last year
Pharma

Ap­peals court re­vives suit against Sanofi's Gen­zyme over ac­cess to Fab­ry dis­ease drug

Last year
Manufacturing

As­traZeneca asks fed­er­al judge to de­cide in its fa­vor in drug price ne­go­ti­a­tions law­suit

Last year
Pharma

GSK wins ap­peal to on­ly pay As­traZeneca roy­al­ties on some sales of can­cer drug Ze­ju­la

Last year
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times